Management of Breakthrough Seizures in Patients on Subtherapeutic Carbamazepine

Therapeutic Drug Monitoring

• The target therapeutic blood level for carbamazepine is 4-8 mcg/mL, and levels should be drawn 4-6 days after each dose adjustment to guide further titration, according to Praxis Medical Insights 1
• Baseline complete blood count and liver function tests are recommended before dose escalation, with ongoing monitoring every 3-6 months if stable, as suggested by Praxis Medical Insights 1

Alternative Considerations

• If seizures persist despite optimized carbamazepine dosing, alternative agents such as levetiracetam or valproate may be considered, with valproate being effective for both partial and generalized seizures, as stated in the Annals of emergency medicine 2

Special Genetic Consideration

• For patients of Asian descent, particularly Han Chinese, HLA-B*15:02 screening should be performed before dose escalation to assess the risk of Stevens-Johnson syndrome, as recommended by Praxis Medical Insights 1 and 3